The present invention relates to compounds of the formula (I)
wherein A, X and R
1
to R
9
are as described herein; to pharmaceutical compositions comprising the said compounds; to processes for their preparation; and to the use of the compounds as medicaments against 5-HT
6
receptor-related disorders.
8-SULFONYL-L, 3, 4, 8-TETRAHYDR0-2H- [1, 4]OXAZEPINO [6, 7-E]INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 RECEPTOR LIGANDS
申请人:BIOVITRUM AB (publ)
公开号:EP2091953A1
公开(公告)日:2009-08-26
US7960374B2
申请人:——
公开号:US7960374B2
公开(公告)日:2011-06-14
[EN] 8-SULFONYL-L, 3, 4, 8-TETRAHYDR0-2H- [1, 4] OXAZEPINO [6, 7-E] INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 RECEPTOR LIGANDS<br/>[FR] DÉRIVÉS DE 8-SULFONYL-1,3,4,8-TÉTRAHYDRO-2H-[1,4]-OXAZÉPINO[6,7-E]INDOLE ET LEUR UTILISATION EN TANT QUE LIGANDS DU RÉCEPTEUR 5-HT6
申请人:BIOVITRUM AB PUBL
公开号:WO2008054288A1
公开(公告)日:2008-05-08
[EN] The present invention relates to compounds of the formula (I) wherein A, X and R1 to R9 are as described herein; to pharmaceutical compositions comprising the said compounds; to processes for their preparation; and to the use of the compounds as medicaments against 5-HT6 receptor-related disorders. [FR] La présente invention concerne des composés de formule (I) dans laquelle A, X et R1 à R9 sont tels que décrits dans le présent document ; des compositions pharmaceutiques comprenant lesdits composés ; des procédés de préparation desdits composés ; et l'utilisation des composés en tant que médicaments contre les troubles associés au récepteur 5-HT6.